U-Blot® Research Grade VantictumabCat. No. WA3748Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade VantictumabCat. No. WA3748
U-Blot® Research Grade VandortuzumabCat. No. WA3747
U-Blot® Research Grade VanalimabCat. No. WA3746
U-Blot® Research Grade VamikibartCat. No. WA3745
U-Blot® Research Grade ValzifloceptCat. No. WA3744
U-Blot® Research Grade valancitugCat. No. WA3743
U-Blot® Research Grade Valanafusp AlfaCat. No. WA3742
U-Blot® Research Grade VAK-694Cat. No. WA3741
U-Blot® Research Grade VadastuximabCat. No. WA3740
U-Blot® Research Grade vadalentamigCat. No. WA3739
U-Blot® Research Grade UtomilumabCat. No. WA3738
U-Blot® Research Grade UstekinumabCat. No. WA3737